The FGL1 level was 2.8-fold in active or inactive SLE and 3.8-fold in pSS with low or moderate to high disease activity, but ~10-fold in RA with low to high disease activity, higher than in healthy subjects (Figure 3D). This evidence concerns the gene FGL1 and systemic lupus erythematosus.